Search by Drug Name or NDC
NDC 00121-0935-16 Docusate Sodium 50 mg/5mL Details
Docusate Sodium 50 mg/5mL
Docusate Sodium is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Pharmaceutical Associates, Inc.. The primary component is DOCUSATE SODIUM.
MedlinePlus Drug Summary
Stool softeners are used on a short-term basis to relieve constipation by people who should avoid straining during bowel movements because of heart conditions, hemorrhoids, and other problems. They work by softening stools to make them easier to pass.
Related Packages: 00121-0935-16Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Stool Softeners
Product Information
NDC | 00121-0935 |
---|---|
Product ID | 0121-0935_c9acc4ea-adee-3c73-e053-2a95a90a9702 |
Associated GPIs | 46500010300910 |
GCN Sequence Number | 003017 |
GCN Sequence Number Description | docusate sodium LIQUID 50 MG/5 ML ORAL |
HIC3 | D6S |
HIC3 Description | LAXATIVES AND CATHARTICS |
GCN | 09131 |
HICL Sequence Number | 001326 |
HICL Sequence Number Description | DOCUSATE SODIUM |
Brand/Generic | Generic |
Proprietary Name | Docusate Sodium |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Docusate Sodium Liquid |
Product Type | HUMAN OTC DRUG |
Dosage Form | LIQUID |
Route | ORAL |
Active Ingredient Strength | 50 |
Active Ingredient Units | mg/5mL |
Substance Name | DOCUSATE SODIUM |
Labeler Name | Pharmaceutical Associates, Inc. |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH NOT FINAL |
Application Number | part334 |
Listing Certified Through | 2024-12-31 |
Package
Package Images



NDC 00121-0935-16 (00121093516)
NDC Package Code | 0121-0935-16 |
---|---|
Billing NDC | 00121093516 |
Package | 473 mL in 1 BOTTLE (0121-0935-16) |
Marketing Start Date | 2021-08-16 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 0.02123 |
Pricing Unit | ML |
Effective Date | 2024-01-17 |
NDC Description | DOCUSATE SODIUM 50 MG/5 ML LIQ |
Pharmacy Type Indicator | C/I |
OTC | Y |
Explanation Code | 4, 5 |
Classification for Rate Setting | G |
As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis
Standard Product Labeling (SPL)/Prescribing Information SPL e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 Details
Uses
Warnings
Ask a doctor before use if you have
- stomach pain
- nausea
- vomiting
- noticed a sudden change in bowel habits that lasts over 2 weeks
Directions
- Dose once daily
- take with 6 to 8 oz of milk, juice or infant formula to mask the bitter taste.
adults and children 12 years and older | 5 to 20 mL (1 to 4 teaspoonfuls) |
children 6 to under 12 years of age | 5 to 10 mL (1 to 2 teaspoonfuls) |
children 3 to under 6 years of age | 2.5 to 5 mL (1/2 to 1 teaspoonful) |
children under 3 years | ask a doctor |
Other information
- • Sodium content: 14 mg/ 5 mL
• Store at controlled room temperature, 20° to 25°C (68° to 77°F)
• Protect from freezing
• Protect from light
• Clear pink to purple-pink colored, cherry flavored liquid supplied in the following:
NDC 0121-0935-16: 16 fl oz (473 mL) bottle
NDC 0121-0935-05: 5 mL unit dose cup, in a tray of ten cups.
NDC 0121-1870-10: 10 mL unit dose cup, in a tray of ten cups.
Inactive ingredients
PRINCIPAL DISPLAY PANEL - 16 fl oz (473 mL)
PRINCIPAL DISPLAY PANEL - 5 mL Cup Tray Label
PRINCIPAL DISPLAY PANEL - 10 mL Cup Tray Label
INGREDIENTS AND APPEARANCE
DOCUSATE SODIUM
docusate sodium liquid liquid |
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
DOCUSATE SODIUM
docusate sodium liquid liquid |
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
Labeler - Pharmaceutical Associates, Inc. (044940096) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Pharmaceutical Associates, Inc. | 097630693 | manufacture(0121-0935, 0121-1870) |
Revised: 9/2021
Document Id: c9acc4ea-adee-3c73-e053-2a95a90a9702
Set id: e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5
Version: 1
Effective Time: 20210915